Clinical trial
Study to Investigate Efficacy and Safety of a New Oral Contraceptive
NCT00185289 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185289 |
|---|---|
| Title | Study to Investigate Efficacy and Safety of a New Oral Contraceptive |
| Official title | Multi-center , Open, Uncontrolled Study to Investigate the Efficacy and Safety of a 4 Phasic Oral Contraceptive SH T00658 in a 28-day Regimen for 20 Cycles in Healthy Female Volunteers |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | EV/DNG (Qlaira, BAY86-5027, SH T00658K) |
| Enrollment | 1,392 |
| Start date | Apr 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 15, 2011 |
| Countries | Austria, Germany, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: